# GlaxoWellcome Production - Inspection Records

Source: https://www.globalkeysolutions.net/companies/glaxowellcome-production/f88b8738-02c0-496c-bdc6-4d9f893e1cb8

> Inspection records and compliance data for GlaxoWellcome Production in Evreux, None. Access full analysis and detailed observations.

---

## Details

- Name: GlaxoWellcome Production
- FEI Number: 3002807436
- City: Evreux
- State: None
- Country Name: France
- Address Line 1: Zone Industrielle 2, 23 Rue Lavoisier
- Zip Code: None

## Related Documents

- [FDA Inspection 1242271 - GlaxoWellcome Production - 2022-04-08](https://www.globalkeysolutions.net/records/fda_inspections/glaxowellcome-production/20e1d573-049b-4112-8240-f10261c65444) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 8, 2022
- [FDA Inspection 1005796 - GlaxoWellcome Production - 2017-03-03](https://www.globalkeysolutions.net/records/fda_inspections/glaxowellcome-production/b673f0a0-aaff-450b-b76a-74f9a1411f35) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 3, 2017
- [FDA Inspection 886660 - GlaxoWellcome Production - 2014-04-11](https://www.globalkeysolutions.net/records/fda_inspections/glaxowellcome-production/e4e092cb-d373-415d-ba98-4c6896833c08) — classification: No Action Indicated (NAI), source: FDA, date: April 11, 2014
- [FDA Inspection 772742 - GlaxoWellcome Production - 2012-02-27](https://www.globalkeysolutions.net/records/fda_inspections/glaxowellcome-production/26c5734a-d28c-4562-b34f-1069d1f34bf5) — classification: No Action Indicated (NAI), source: FDA, date: February 27, 2012
- [FDA Inspection 572931 - GlaxoWellcome Production - 2009-03-19](https://www.globalkeysolutions.net/records/fda_inspections/glaxowellcome-production/f810f8e2-738a-47ae-a4fa-1bed8021c1aa) — classification: No Action Indicated (NAI), source: FDA, date: March 19, 2009

## Related Companies

- [Macleods Pharmaceuticals Limited, Sarigam](https://www.globalkeysolutions.net/companies/macleods-pharmaceuticals-limited-sarigam/d9c73faa-dc0c-4437-9ea8-cb24f8a08d11)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)](https://www.globalkeysolutions.net/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-jinqiao-road-site/78556cbd-f0c8-40a5-a1f2-3ab0dce403ee)
- [Glaxo Operations UK Limited](https://www.globalkeysolutions.net/companies/glaxo-operations-uk-limited/203ed5e0-7ae4-490f-b37a-9293e17eae84)
- [West-Ward Columbus Inc](https://www.globalkeysolutions.net/companies/west-ward-columbus-inc/6289cb89-1444-49a0-91b0-75a04e5152eb)
- [GE Healthcare Inc.](https://www.globalkeysolutions.net/companies/ge-healthcare-inc/b959f09c-3de8-449e-bed3-d919c59edf59)
- [Elanco Clinton Laboratories](https://www.globalkeysolutions.net/companies/elanco-clinton-laboratories/89925321-ecbd-43b1-b3a1-472fd17439a0)
- [Excella GmbH & Co. KG](https://www.globalkeysolutions.net/companies/excella-gmbh-co-kg/82bb94ef-8b2e-4e51-8c40-b71a184257f1)
- [TriRx Speke Limited](https://www.globalkeysolutions.net/companies/trirx-speke-limited/51c2b1a3-44be-420c-83eb-3eb1dee37cea)
- [Piramal Pharma Limited](https://www.globalkeysolutions.net/companies/piramal-pharma-limited/426a2612-5a5c-4bc9-9073-420430b16072)
- [Ipsen BioPharm Ltd](https://www.globalkeysolutions.net/companies/ipsen-biopharm-ltd/282b5a9a-91d6-43f7-b345-aa6fede30025)